The fast-selling GLP-1 drug matched Lilly's older medicine Trulicity in a closely watched cardiovascular outcomes trial, while showing greater weight loss and blood sugar control.

Our intestines are home to trillions of microorganisms that produce substances capable of regulating all the body's organs via the bloodstream and the gut's nervous system.

Obesity drugmaker Novo Nordisk on Tuesday cut its full-year sales and operating profit forecasts for the second time this ...

For a while, Danish drugmaker Novo Nordisk A/S looked unstoppable. It was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat ...

Women using a certain type of hormone therapy to treat menopause symptoms could be at higher risk for breast cancer, according to a new study. The study, published Tuesday in The Lancet Oncology ...

US Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels on hormone replacement therapy, following testimony from experts who ...

Puerto Rico's governor has signed a bill that prohibits hormone therapy or gender-affirming surgeries for transgender youth, a move that has drawn sharp criticism from activists in the largely ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide treatment alone ...

DelveInsight's THR-β Agonist Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

The Danish government and the foundation behind Novo Nordisk A/S will invest €80 million ($93 million) in a Microsoft-powered quantum computer to boost technological development in the Nordic ...

Miah’s decade-long battle to be at peace with her body – which she says is due to health concerns rather than body image – has seen her explore a rollercoaster of weightloss methods, from fad diets to ...

Puerto Rico’s governor has signed a bill that prohibits hormone therapy or gender-affirming surgeries for transgender youth.